{"id":"W2984163037","doi":"10.1182/blood-2019-123449","title":"Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Jewish General Hospital; Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Internal medicine; Refractory (planetary science); Phases of clinical research; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003491858,0.0006769565,0.001996999,0.0004168661,0.0001828698,0.001526107,0.0006063302,0.0006042289,0.002471758],"category_scores_gemma":[0.002812669,0.000432589,0.002051047,0.0006021403,0.0004021253,0.0008449378,0.00037327,0.001886231,0.0003971446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007958743,"about_ca_system_score_gemma":0.0008785428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007452634,"about_ca_topic_score_gemma":0.002150849,"domain_scores_codex":[0.9987782,0.0006525054,0.0001413549,0.0001597506,0.0001749602,0.00009334713],"domain_scores_gemma":[0.9984176,0.0004895387,0.0005272245,0.0001205065,0.0001860338,0.0002590616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.763063,0.004057496,0.01172189,0.004760729,0.01505589,0.00016341,0.0002158707,0.001409468,0.007566933,0.0003775672,0.00558447,0.1860233],"study_design_scores_gemma":[0.8400866,0.08305269,0.03703538,0.0008123073,0.02165622,0.0004983553,0.0001451254,0.001174452,0.001451091,0.0006569814,0.01336545,0.00006533223],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9116653,0.07202483,0.001399878,0.002204362,0.0007719995,0.002726776,0.004683841,0.0001292127,0.004393855],"genre_scores_gemma":[0.9622096,0.02254123,0.002454223,0.002749713,0.0005604733,0.001747139,0.005860206,0.000043038,0.001834363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003491858,"threshold_uncertainty_score":0.01846695,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01411623248278604,"score_gpt":0.3040344386412057,"score_spread":0.2899182061584197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}